Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project
Ellen B. Dennehy(Eli Lilly (United States)), T. Michael Kashner(The University of Texas Southwestern Medical Center), A. John Rush, M. Lynn Crismon(The University of Texas Southwestern Medical Center), Thomas Carmody, Madhukar H. Trivedi(University of Illinois Chicago), Alexander L. Miller(Northwell Health), Trisha Suppes(Stanford University)
Cited by 52
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
|Psychological Medicine|2004|989
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
|New England Journal of Medicine|2007|925
Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program
|American Journal of Psychiatry|2015|849